Login

Componenta as an Investment - Investor Day 28.11.2022| Sami Sivuranta , CEO of Componenta 00:10:00

Share On Facebook Share On Twitter

Sami Sivuranta is President/CEO/IR at Componenta OYJ.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Introducing the Aurora Class: Largest Zero Carbon Ready Car Carrier | Andreas Enger - CEO of Hoegh Autoliners
00:10:00
Works with young founders solving high-impact problems|Alex Fiance,Co-Founder & Co-CEO,Kairos HQ
00:10:00
Approach is to lead with an entrepreneurial mindset, partnering with their portfolio companies|Liz Cohen, Head of Contet,Hetz Ventures
00:10:00
Spotlight on Small-Cap Growth: Morningstar’s Positive Outlook on Artemis UK Smaller Companies | Jonathan Miller - Director of Manager Research, UK, Morningstar
00:10:00
Prof. Daniel Kahneman: The Art and Science of Decision Making – A Deep Dive into Human Choices in Business, Science, and Life with Nobel Laureate and Behavioral Economist
00:10:00
Managing Director and Founder, Mr. Adam Bloomer, and Chief Executive Officer, Dr. Jessica North from LGI Ltd, presented at our latest Morgans event.
00:10:00
Sun Metals: Overview and Exploration Progress
00:10:00
Unbound Group PLC CEO Ian Watson Discusses Growth Plans and Market Debut | Ian Watson, CEO, Unbound Group PLC.
00:10:00
"JoAnn Price on Investing in Emerging Fund Managers | Fairview Capital Partners"
00:10:00
Townsville Energy Chemical Hub (TECH): Revolutionizing Nickel Processing with Innovative Nitric Acid Method
00:10:00
Interview with Robert Crayford and Keith Watson: Insights into Geiger Counter Limited and the Uranium Market
00:10:00
The Canadian Securities Exchange: Low-Cost Access and Growth for Companies

© 2017 - Neuhu+